Table III.
Distribution of Autosomal CNVs in TS Cases and Controls
All | >200 Kb | rare events | rare genic | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
TS | Controls | P | TS | Controls | P | TS | Controls | P | TS | Controls | P | |
Total autosomal CNVs | 1282 | 56425 | 0.003 | 303 | 13419 | 0.004 | 419 | 17541 | 0.005 | 179 | 7528 | 0.4 |
Deletions | 409 | 29247 | 0.0009 | 86 | 3398 | 0.03 | 143 | 9815 | 0.0003 | 47 | 4382 | 0.002 |
Duplications | 873 | 27178 | 0.0002 | 217 | 10021 | 0.003 | 276 | 7726 | 0.0005 | 132 | 3146 | 1.0×10−6 |
TS: 418 Turner syndrome genotypes; ETAAD: 110 early onset TAAD genotypes; Controls: 15,414 genotypes from four dbGAP datasets; P: P-values for comparisons with controls. TS CNV rates (total length of CNVs per individual or average size of CNVs) were uniformly increased across all CNV categories vs controls and were comparable to ETAAD CNV rates. In contrast, TS CNV rates were not significantly different from ETAAD CNV rates across all CNV categories (P=0.12-0.98).